Wirk, Baldeep, and Jin Lim. “Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma”. Journal of Hematology, Apr. 2025, https://doi.org/10.14740/jh2046.